Mayo Clinic's Translational Neuromuscular Disease Research Lab led by Nathan P. Staff, M.D., Ph.D., studies the biological ...
Veterans who developed neurodegenerative conditions after deploying to Afghanistan and Iraq are being sought for a NASEM ...
Scientists have discovered that increased expression of a novel long non-coding RNA drives glioblastoma cell growth alongside ...
FDA acceptance positions 18F-FET as a potential first-in-class US-approved amino acid PET agent for glioma characterization, addressing a major posttreatment imaging specificity gap.
Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma
CHANHASSEN, Minn., April 9, 2026 /PRNewswire/ -- Alpheus Medical, Inc., a private, clinical-stage biotechnology company, today announced the initiation of its Phase 2b randomized controlled trial in ...
How does Alzheimer’s target specific brain cells? Researchers are building a multiscale model of the hippocampus to map neuronal loss and cognitive decline.
Neuro Salt has prompted a comprehensive independent investigation into its claims and ingredients following explosive ...
Epia Neuro’s brain-computer interface will include a motorized glove to help stroke patients recover movement in their hand.
How does brain metabolism affect aging? Researchers received a $3.3M NIH grant to study neurometabolic coupling and Alzheimer ...
If you’ve been living with constant ringing, muffled sounds, or the creeping fear of hearing decline, you already know ...
In the field of neuro-oncology, the dual topics of cellular metabolism and the tumor microenvironment (TME) have gained significant traction, particularly when addressing brain tumors such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results